Search by Drug Name or NDC

    NDC 65219-0188-10 ketamine hydrochloride 50 mg/mL Details

    ketamine hydrochloride 50 mg/mL

    ketamine hydrochloride is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is KETAMINE HYDROCHLORIDE.

    Product Information

    NDC 65219-0188
    Product ID 65219-188_fca3eb6b-16e4-403e-9d65-71f15d9b2c45
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ketamine hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name ketamine hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name KETAMINE HYDROCHLORIDE
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class General Anesthesia [PE], General Anesthetic [EPC]
    DEA Schedule CIII
    Marketing Category ANDA
    Application Number ANDA215808
    Listing Certified Through 2024-12-31

    Package

    NDC 65219-0188-10 (65219018810)

    NDC Package Code 65219-188-10
    Billing NDC 65219018810
    Package 10 VIAL in 1 TRAY (65219-188-10) / 10 mL in 1 VIAL (65219-188-01)
    Marketing Start Date 2023-07-10
    NDC Exclude Flag N
    Pricing Information N/A